CNMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 158.8% based on the discounted cash flow analysis.
| Market cap | $1.07 Billion |
|---|---|
| Enterprise Value | $1.90 Billion |
| Dividend Yield | $0.40 (1.12%) |
| Earnings per Share | $1.52 |
| Beta | 0.94 |
| Outstanding Shares | 30,588,000 |
| P/E Ratio | 19.91 |
|---|---|
| PEG | 15.42 |
| Price to Sales | 0.8 |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 1.39 |
| Enterprise Value to EBIT | 16.61 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.85 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3760▲ 37.60% |
|---|---|
| Total Calls | 100,000▲ 1718.18% |
| Total Puts | 37,600▲ Infinity% |
Holdings and activity of institutional investors.
| Ownership % | 109.39%▼ 0.37% |
|---|---|
| Total Invested | $1.20B▼ 13.02% |
| Investors Holding | 239▼ 26.00% |
No data
This committee's analyses and 'revenue estimates' are foundational to tax legislation, directly influencing corporate tax structures, capital investment credits, and overall fiscal policy, which significantly affects Conmed's financial performance.
This committee's control over taxation, trade, and entitlement spending, particularly Medicare pricing, directly and significantly impacts the profitability, market access, and overall financial health of a medical device manufacturer like Conmed.
This committee directly controls federal spending allocations, which includes budgets for federal healthcare programs (e.g., VA, DoD hospitals) that purchase medical devices. Its decisions directly impact revenue streams from government contracts.
This committee directly regulates the FDA, which is the primary regulatory body for medical devices. Decisions regarding device approvals, safety standards, and manufacturing oversight are paramount to Conmed's business. Labor laws also impact its operational costs.
Intellectual property protection (patents) is crucial for medical device manufacturers like Conmed. The committee's oversight of antitrust laws also directly impacts potential mergers and acquisitions within the industry.
Conmed likely supplies medical devices to the Department of Veterans Affairs (VA) hospitals. This committee's funding decisions directly impact government healthcare contractors and procurement for veterans' healthcare.